Glen Eagle Advisors’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.7K | Sell |
1,386
-299
| -18% | -$13.6K | 0.01% | 414 |
|
|
2025
Q4 | $74.7K | Buy |
1,685
+302
| +22% | +$13K | 0.01% | 370 |
|
|
2025
Q3 | $58.4K | Sell |
1,383
-31
| -2% | -$1.25K | 0.01% | 421 |
|
|
2025
Q2 | $51.8K | Buy |
1,414
+2
| +0.1% | +$74 | 0.01% | 420 |
|
|
2025
Q1 | $53.8K | Buy |
1,412
+2
| +0.1% | +$74 | 0.01% | 401 |
|
|
2024
Q4 | $53.4K | Buy |
1,410
+2
| +0.1% | +$80 | 0.01% | 405 |
|
|
2024
Q3 | $57.3K | Buy |
1,408
+2
| +0.1% | +$76 | 0.01% | 396 |
|
|
2024
Q2 | $48.2K | Sell |
1,406
-68
| -5% | -$2.14K | 0.01% | 403 |
|
|
2024
Q1 | $46.7K | Sell |
1,474
-35
| -2% | -$1.06K | 0.01% | 417 |
|
|
2023
Q4 | $46.3K | Buy |
1,509
+100
| +7% | +$3.21K | 0.01% | 398 |
|
|
2023
Q3 | $46.7K | Sell |
1,409
-60
| -4% | -$1.92K | 0.01% | 387 |
|
|
2023
Q2 | $45.1K | Sell |
1,469
-70
| -5% | -$2.02K | 0.01% | 390 |
|
|
2023
Q1 | $42.2K | Sell |
1,539
-220
| -13% | -$6.12K | 0.01% | 393 |
|
|
2022
Q4 | $49.2K | Sell |
1,759
-70
| -4% | -$2.11K | 0.01% | 363 |
|
|
2022
Q3 | $53.9K | Sell |
1,829
-261
| -12% | -$8.18K | 0.02% | 340 |
|
|
2022
Q2 | $58.9K | Sell |
2,090
-999
| -32% | -$28.4K | 0.02% | 341 |
|
|
2022
Q1 | $96.3K | Sell |
3,089
-637
| -17% | -$18.8K | 0.03% | 285 |
|
|
2021
Q4 | $110K | Sell |
3,726
-188
| -5% | -$5.49K | 0.03% | 271 |
|
|
2021
Q3 | $117K | Buy |
3,914
+10
| +0.3% | +$344 | 0.03% | 259 |
|
|
2021
Q2 | $142K | Buy |
3,904
+85
| +2% | +$3.16K | 0.04% | 231 |
|
|
2021
Q1 | $140K | Buy |
3,819
+194
| +5% | +$7.14K | 0.05% | 221 |
|
|
2020
Q4 | $132K | Sell |
3,625
-1,123
| -24% | -$38.1K | 0.05% | 207 |
|
|
2020
Q3 | $142K | Buy |
4,748
+500
| +12% | +$15.6K | 0.06% | 187 |
|
|
2020
Q2 | $126K | Hold |
4,248
| – | – | 0.06% | 187 |
|
|
2020
Q1 | $113K | Sell |
4,248
-225
| -5% | -$8.54K | 0.08% | 178 |
|
|
2019
Q4 | $189K | Buy |
4,473
+2,213
| +98% | +$93.7K | 0.1% | 169 |
|
|
2019
Q3 | $94.4K | Sell |
2,260
-75
| -3% | -$2.92K | 0.06% | 203 |
|
|
2019
Q2 | $85.8K | Buy |
2,335
+710
| +44% | +$25.9K | 0.06% | 212 |
|
|
2019
Q1 | $62K | Hold |
1,625
| – | – | 0.05% | 246 |
|
|
2018
Q4 | $57.1K | Buy |
1,625
+455
| +39% | +$15.8K | 0.05% | 234 |
|
|
2018
Q3 | $38.3K | Buy |
1,170
+450
| +63% | +$14.3K | 0.03% | 301 |
|
|
2018
Q2 | $22.3K | Buy |
720
+270
| +60% | +$7.72K | 0.02% | 354 |
|
|
2018
Q1 | $12.2K | Sell |
450
-770
| -63% | -$20.5K | 0.01% | 415 |
|
|
2017
Q4 | $33.6K | Sell |
1,220
-575
| -32% | -$16.6K | 0.03% | 284 |
|
|
2017
Q3 | $57.3K | Buy |
1,795
+420
| +31% | +$13.5K | 0.05% | 227 |
|
|
2017
Q2 | $45.4K | Buy |
1,375
+75
| +6% | +$2.48K | 0.04% | 222 |
|
|
2017
Q1 | $42.9K | Hold |
1,300
| – | – | 0.04% | 215 |
|
|
2016
Q4 | $40.6K | Buy |
+1,300
| New | +$40.1K | 0.04% | 213 |
|
Other funds holding OHI
VPM
VCM
Glen Eagle Advisors's OHI Position: Q1 2026 in Review
Glen Eagle Advisors reduced its Omega Healthcare (OHI) stake by 18% in Q1 2026, selling an estimated $13.6K and leaving 1,386 shares worth $60.7K. The position accounts for 0.01% of the portfolio, ranked #414.
Glen Eagle Advisors first reported a position in OHI in Q4 2016 and has held it in 38 quarters since. The position peaked at $189K in Q4 2019. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- Glen Eagle Advisors held 1,386 shares of Omega Healthcare worth $60.7K as of Q1 2026.
- Glen Eagle Advisors sold 299 Omega Healthcare shares in Q1 2026, an estimated $13.6K.
- Omega Healthcare made up 0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #414 holding.
- Glen Eagle Advisors first reported a position in Omega Healthcare in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's Omega Healthcare position peaked at $189K in Q4 2019.
- 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.